InternetIntelligenz 2.0

kostenlos Pressemitteilungen einstellen | veröffentlichen | verteilen

Pressemitteilungen

 

Choroidal Neovascularization - Pipeline Review: Market Research Hub: Share, Forecast Trends, H1 2017

ID: 1490860

Market Research Hub's latest Pharmaceutical and Healthcare disease pipeline guide Choroidal Neovascularization - Pipeline Review, H1 2017, provides an overview of the Choroidal Neovascularization pipeline landscape.


(IINews) - Albany, New York, 12 May, 2017: Market Research Hub''s latest Pharmaceutical and Healthcare disease pipeline guide Choroidal Neovascularization - Pipeline Review, H1 2017, provides an overview of the “Choroidal Neovascularization pipeline landscape”.

Request For Free Sample (at) http://www.marketresearchhub.com/enquiry.php?type=S&repid=1068428

Choroidal neovascularization (CNV) involves the growth of new blood vessels that originate from the choroid Symptoms include painless loss of vision, metamorphopsia, and color disturbances. Treatment includes ant-VEGF agents, laser photocoagulation and photodynamic therapy.

Report Highlights

Market Research Hub''s Pharmaceutical and Healthcare latest pipeline guide Choroidal Neovascularization - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Choroidal Neovascularization (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Choroidal Neovascularization (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Choroidal Neovascularization and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 10 and 2 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 4 molecules, respectively.

Choroidal Neovascularization (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.





Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Choroidal Neovascularization (Ophthalmology).
- The pipeline guide reviews pipeline therapeutics for Choroidal Neovascularization (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Choroidal Neovascularization (Ophthalmology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Choroidal Neovascularization (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Choroidal Neovascularization (Ophthalmology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Choroidal Neovascularization (Ophthalmology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.



Browse Full Report With TOC (at) http://www.marketresearchhub.com/report/choroidal-neovascularization-pipeline-review-h1-2017-report.html


- Formulate corrective measures for pipeline projects by understanding Choroidal Neovascularization (Ophthalmology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.



Themen in diesem Fachartikel:


Unternehmensinformation / Kurzprofil:


About Market Research Hub:

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.




Leseranfragen:

Ajay


ajay.k(at)marketresearchhub.com



PresseKontakt / Agentur:


Contact Details:

90 State Street,

Albany, NY 12207,

United States

Toll Free: 866-997-4948 (US-Canada)

Tel: +1-518-621-2074

Email: press(at)marketresearchhub.com

Website: http://www.marketresearchhub.com/

Follow Us on:

Twitter: https://twitter.com/MktResearchHub

LinkedIn: https://www.linkedin.com/company/market-research-hub

Facebook: https://www.facebook.com/MarketResearchHub/











drucken  als PDF  an Freund senden  Peritoneal Cancer - Pipeline Review: Market Research Report Hub, Share, Trends & Forecast H1 2017
Presseverlage warnen vor Enteignung durch neues Urheberrecht
Bereitgestellt von Benutzer: MarketResearchHub
Datum: 12.05.2017 - 14:47 Uhr
Sprache: Deutsch
News-ID 1490860
Anzahl Zeichen: 0

Kontakt-Informationen:
Ansprechpartner: Ajay
Stadt:

Albany


Telefon: 15186212074

Kategorie:

Medien & Unterhaltung


Anmerkungen:


Dieser Fachartikel wurde bisher 71 mal aufgerufen.


Der Fachartikel mit dem Titel:
"Choroidal Neovascularization - Pipeline Review: Market Research Hub: Share, Forecast Trends, H1 2017
"
steht unter der journalistisch-redaktionellen Verantwortung von

Market Research HUB (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Market Research HUB



 

Wer ist Online

Alle Mitglieder: 50.206
Registriert Heute: 0
Registriert Gestern: 0
Mitglied(er) online: 0
Gäste Online: 123


Bitte registrieren Sie sich hier. Als angemeldeter Benutzer nutzen Sie den vollen Funktionsumfang dieser Seite.